AmirGahremanpourMDMS FACC FSCAI
Cardiology • Cypress, TXInterventional Cardiology, Peripheral Endovascular Interventional Cardiology
HCA Healthcare Houston-Pearland Houston Heart
Dr. Gahremanpour is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
27700 Northwest Fwy Ste 460
Cypress, TX 77433Phone+1 832-838-6088Fax+1 832-838-0922
Education & Training
Texan Cardiovascular Institute2015
Baylor College of Medicine/Texas Heart Institute/Baylor St Luke's Medical CenterFellowship, Cardiovascular Disease, 2012 - 2015- Texan Cardiovascular InstitutePost-Doctoral Fellowship, 2007 - 2012
Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 2004 - 2007- Arizona Heart InstitutePost-Doctoral Fellowship, 2003 - 2004
Shiraz University of Medical SciencesClass of 1998
Certifications & Licensure
MT State Medical License 2022 - 2026
TX State Medical License 2007 - 2026
KS State Medical License 2022 - 2025
OK State Medical License 2022 - 2025
PA State Medical License 2004 - 2007- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
- American Board of Internal MedicibeInterventional Cardiology
Publications & Presentations
PubMed
- 20 citationsRationale and design for PACE: Patients with intermittent claudication injected with ALDH bright cellsEmerson C. Perin, Michael P. Murphy, John P. Cooke, Lem Moyé, Timothy D. Henry
American Heart Journal. 2014-11-01 - 131 citationsA randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF)Emerson C. Perin, Guilherme V. Silva, Timothy D. Henry, Maria da Graça Cabreira-Hansen, W. H. Moore
American Heart Journal. 2011-06-01 - 70 citationsRandomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase–bright stem cells in patients with ischemic heart failureEmerson C. Perin, Guilherme V. Silva, Yi Zheng, Amir Gahremanpour, John Canales
American Heart Journal. 2012-03-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
